A glycoprotein with an approx, mol. wt. of 55000, encoded by spleen focus-forming virus (SFFV), was detected with an antiserum against xenotropic murine leukaemia virus (MuLV) in various cell lines infected with the Friend strain of SFFV, suggesting that the SFFV-specific RNA coding for gp55 is related to the xenotropic virus. The proteins from three cell lines differed from each other in molecular size and gave different peptide maps. The differences in the gp55 molecules were shown to depend on differences in the SFFV genome, but not on differences in glycosylation or processing of the precursor polypeptides of gp55 in the different cells. These results indicate virus strain specificity of SFFV in gp55 formation.
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Rabbit antiserum against xenotropic MuLV (MuLVx) was prepared by injection of rabbit SIRC cells which had been infected by Harvey-MSV pseudotyped with the NZB-IU-1 strain of MuLV x. This virus was rescued from non-producer Harvey-MSV-NRK (Scolnick & Parks, 1974) by superinfection with the NZB-IU-1 strain of MuLV x (Hartley & Rowe, 1976) . This antiserum neutralized the infectivity of NZB-MuLV x, but not of the ecotropic FN2 virus (M. Yoshida & H. Yoshikura, unpublished data) . Goat antiserum to gp70 of Rauscher MuLV (R-MuLV) was a generous gift from Dr T. August of Johns Hopkins University. Labelling the cells with 3~S-methionine and preparation of the extract were carried out according to Brugge et al. (1978) . Immunoprecipitation of the labelled proteins was carried out as described by Kessler (1975) . The method of Cleveland et al. (1977) was used for the peptide analysis by partial digestion with Staphylococcus protease V8.
It had been previously established that SFFV contains specific R N A sequences in the 5'-and 3'-half of the genome and that in the 3'-half encodes a glycoprotein, gp55. On the other hand, the SFFV-specific R N A sequences were reported to be partly homologous to those of MuLV x (Troxler et al., 1977b) . To determine whether the SFFV-specific R N A sequences coding for gp55 are related to MuLV x R N A sequences, the cross-reactivity of an antiserum against MuLV x with gp55 was tested. Like anti-gp70 of R-MuLV, anti-MuLV x serum precipitated gp55 from three cell lines (FV131-SC-1, F V T C T and S F F V -N R K ) infected with the Friend strain of SFFV (Fig. 1 a) . Peptide analysis (Fig. 1 b) demonstrated that the gp55 proteins isolated with anti-MuLV x and anti-gp70 of R-MuLV were identical. The specificity of anti-MuLV x serum was confirmed by two findings: (i) antiserum to MuLV x did not significantly cross-react with the gp70 of ecotropic FN2 (Fig. 1 a) and (ii) the reactivity of anti-MuLV X with gp55 could not be reduced by adding a large excess of extract of cells infected with FN2, but could by adding the extract of cells infected with NZB-IU-1 strain of MuLVx (data not shown). These results indicate that gp55 has antigenic determinants related to MuLV~, consequently suggesting that at least a part of the SFFV-speeific RNA sequences coding for gp55 are related to MuLV~. Since Dresler et al. (1979) have reported that gp55 reacted with antiserum to eeotropie helper MuLV, our findings suggest that the gp55 protein is a hybrid molecule between gp70 proteins of xeno-and ecotropic MuLV, and they are in good agreement with the report by Troxler et al. (1977 c) that SFFV RNA is a recombinant between xeno-and ecotropic MuLV at the env gene.
At the same time, Fig. 1 demonstrated size differences between the gp55 obtained from the different cell lines. These differences were demonstrated more directly by partial digestion of each protein with Staphylococcus protease V8 and examination of the digestion products by polyacrylamide gel electrophoresis (Fig. 2) . Seven to nine peptides containing methionine were detected, and six of them (bands 1 to 6) were common to the gp55 proteins isolated from the three cell lines. However, the smaller peptides containing methionine (bands a to g) of the gp55 were different. Band a was common to the gp55 proteins of FV 131-SC-1 and FVTCT, but not to SFFV-NRK gp55. On the other hand, band c was common to the gp55 proteins of FVTCT and SFFV-NRK, but not to FV131-SC-1 gp55. The other bands were specific to each gp55 protein. These results clearly indicate that the gp55 proteins detected in FV 131-SC-1, FVTCT and SFFV-NRK cells are not identical, although very similar.
This cell line specificity of gp55 might simply reflect differences in modification of the gp55 precursor polypeptide (Dresler et al., 1979) , since the cell lines used were very different in their origins: FV131-SC-1 is a mouse fibroblast, FVTCT originated from a reticulum cell tumour of a Balb/c mouse and SFFV-NRK is a rat cell line. To test this possibility, non-producer SFFV-NRK cells were superinfected with the FN2 helper MuLV and the rescued virus, SFFV(FN2), was used to infect SC-1 and NRK cells. These cells were then labelled with 35S-methionine and the virus proteins were precipitated with antiserum to the gp70 of R-MuLV. Almost identical gel patterns of the immunoprecipitated proteins were observed in both SC-1 and NRK cells infected with SFFV(FN2) (data not shown). The gp55 proteins in SFFV(FN2)-SC-1 and -NRK cells were characterized further by analysis of their peptide composition using protease V8 (Fig. 2, D and E) . The peptide compositions of the gp55 proteins in both cells were identical, and the same as that of the original gp55 in SFFV-NRK, but different from that of gp55 in FV131-SC-1 cells. These results clearly indicate that the differences in size and peptide composition of gp55 are related to the SFFV genome strain, and could not be explained by the differences in the type of cells in which the genome is expressed.
Since the SFFV is a recombinant virus, and gp55 shares immunological reactivity with xeno-and ecotropic MuLV, the observed strain specificity of gp55 could be explained as follows: SFFV in the original FLV preparation may have been a mixture formed by recombination at different sites within the env gene, and subsequent passage in different strains of mice may have selected for one of the SFFV genomes. Alternatively, the SFFV genome may have changed during the many passages in different mice by mutations and/or recombination with endogenous viruses or cellular sequences. The strain specificity of SFFV for gag-related polypeptides was reported very recently (Ruscetti et al., 1980) . Strain-specific proteins which are not essential to virus replication have also been demonstrated in avian sarcoma virus. The src gene products differ in size, peptide composition and immunospecificity (Beemon & Hunter, 1978; Brugge et al., 1978) , but all have protein kinase activity. By analogy, gp55 proteins, which may not be required for virus replication, may all have similar functions in infected cells even though they show polymorphism. 
